Sigma Planning Corp Reduces Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Sigma Planning Corp decreased its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 43.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 14,071 shares of the pharmacy operator’s stock after selling 10,769 shares during the period. Sigma Planning Corp’s holdings in Walgreens Boots Alliance were worth $367,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Highlander Capital Management LLC bought a new stake in shares of Walgreens Boots Alliance in the 4th quarter worth about $26,000. Venturi Wealth Management LLC increased its position in shares of Walgreens Boots Alliance by 1,241.8% in the 4th quarter. Venturi Wealth Management LLC now owns 1,060 shares of the pharmacy operator’s stock worth $28,000 after purchasing an additional 981 shares during the last quarter. EverSource Wealth Advisors LLC increased its position in shares of Walgreens Boots Alliance by 308.4% in the 3rd quarter. EverSource Wealth Advisors LLC now owns 1,119 shares of the pharmacy operator’s stock worth $25,000 after purchasing an additional 845 shares during the last quarter. Rocky Mountain Advisers LLC bought a new stake in shares of Walgreens Boots Alliance in the 4th quarter worth about $30,000. Finally, Planned Solutions Inc. bought a new stake in shares of Walgreens Boots Alliance in the 4th quarter worth about $34,000. Hedge funds and other institutional investors own 58.59% of the company’s stock.

Wall Street Analyst Weigh In

WBA has been the subject of several research analyst reports. Truist Financial reissued a “hold” rating and issued a $25.00 target price on shares of Walgreens Boots Alliance in a research report on Monday, April 1st. UBS Group dropped their target price on shares of Walgreens Boots Alliance from $25.00 to $22.00 and set a “neutral” rating for the company in a research report on Wednesday, April 3rd. Morgan Stanley dropped their price objective on shares of Walgreens Boots Alliance from $21.00 to $20.00 and set an “underweight” rating on the stock in a research note on Monday, April 1st. Leerink Partnrs reiterated a “market perform” rating on shares of Walgreens Boots Alliance in a research note on Monday, February 26th. Finally, Bank of America dropped their price objective on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set an “underperform” rating on the stock in a research note on Tuesday, March 26th. Four investment analysts have rated the stock with a sell rating, ten have issued a hold rating and two have assigned a buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $24.36.

Insider Activity

In related news, Director Valerie B. Jarrett acquired 4,456 shares of the firm’s stock in a transaction dated Monday, January 29th. The stock was acquired at an average cost of $22.44 per share, for a total transaction of $99,992.64. Following the completion of the acquisition, the director now directly owns 4,456 shares of the company’s stock, valued at approximately $99,992.64. The transaction was disclosed in a legal filing with the SEC, which is available at this link. In related news, Director Valerie B. Jarrett acquired 4,456 shares of the firm’s stock in a transaction dated Monday, January 29th. The stock was acquired at an average cost of $22.44 per share, for a total transaction of $99,992.64. Following the completion of the acquisition, the director now directly owns 4,456 shares of the company’s stock, valued at approximately $99,992.64. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Inderpal S. Bhandari bought 3,000 shares of Walgreens Boots Alliance stock in a transaction that occurred on Thursday, April 11th. The shares were acquired at an average price of $18.05 per share, with a total value of $54,150.00. Following the completion of the acquisition, the director now directly owns 3,000 shares of the company’s stock, valued at approximately $54,150. The disclosure for this purchase can be found here. Insiders purchased 13,456 shares of company stock worth $270,423 over the last three months. Corporate insiders own 17.40% of the company’s stock.

Walgreens Boots Alliance Price Performance

NASDAQ WBA opened at $17.70 on Friday. Walgreens Boots Alliance, Inc. has a 52 week low of $17.49 and a 52 week high of $35.38. The company has a current ratio of 0.66, a quick ratio of 0.32 and a debt-to-equity ratio of 0.50. The stock has a market cap of $15.27 billion, a price-to-earnings ratio of -2.53, a price-to-earnings-growth ratio of 1.09 and a beta of 0.73. The company has a 50-day moving average price of $20.01 and a two-hundred day moving average price of $21.77.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 EPS for the quarter, topping the consensus estimate of $0.82 by $0.38. The firm had revenue of $37.05 billion during the quarter, compared to analysts’ expectations of $35.86 billion. Walgreens Boots Alliance had a negative net margin of 4.18% and a positive return on equity of 12.11%. Walgreens Boots Alliance’s quarterly revenue was up 6.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.16 EPS. Analysts forecast that Walgreens Boots Alliance, Inc. will post 3.23 EPS for the current year.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.